Animal Reproduction Science, ISSN 0378-4320, 2005, Volume 88, Issue 1, pp. 115 - 126
GnRH analogues have achieved widespread clinical use for the control of reproduction in animals. Over 2000 analogues of GnRH have been developed and tested...
Deslorelin | GnRH potency | GnRH analogue | GnRH agonist | GnRH antagonist | ABSORPTION ENHANCEMENT | AGRICULTURE, DAIRY & ANIMAL SCIENCE | GONADOTROPIN-RELEASING-HORMONE | VAGINAL ABSORPTION | LONG-TERM SUPPRESSION | LUTEINIZING-HORMONE | deslorelin | REPRODUCTIVE BIOLOGY | LH-RH | BIOLOGICAL-ACTIVITY | BINDING-AFFINITY | FOLLICLE-STIMULATING-HORMONE | PITUITARY-GONADAL FUNCTION | Amino Acid Sequence | Triptorelin Pamoate - pharmacology | Drug Evaluation | Gonadotropin-Releasing Hormone - administration & dosage | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Structure-Activity Relationship | Gonadotropin-Releasing Hormone - analogs & derivatives | Drug Delivery Systems | Animals | Gonadotropin-Releasing Hormone - chemistry | Triptorelin Pamoate - analogs & derivatives | Receptors, LHRH - metabolism | Triptorelin Pamoate - chemistry | Enzymes | Histamine | Peptides | Heterocyclic compounds | Analysis | Estrogen | Antagonists | Hormones
Deslorelin | GnRH potency | GnRH analogue | GnRH agonist | GnRH antagonist | ABSORPTION ENHANCEMENT | AGRICULTURE, DAIRY & ANIMAL SCIENCE | GONADOTROPIN-RELEASING-HORMONE | VAGINAL ABSORPTION | LONG-TERM SUPPRESSION | LUTEINIZING-HORMONE | deslorelin | REPRODUCTIVE BIOLOGY | LH-RH | BIOLOGICAL-ACTIVITY | BINDING-AFFINITY | FOLLICLE-STIMULATING-HORMONE | PITUITARY-GONADAL FUNCTION | Amino Acid Sequence | Triptorelin Pamoate - pharmacology | Drug Evaluation | Gonadotropin-Releasing Hormone - administration & dosage | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Structure-Activity Relationship | Gonadotropin-Releasing Hormone - analogs & derivatives | Drug Delivery Systems | Animals | Gonadotropin-Releasing Hormone - chemistry | Triptorelin Pamoate - analogs & derivatives | Receptors, LHRH - metabolism | Triptorelin Pamoate - chemistry | Enzymes | Histamine | Peptides | Heterocyclic compounds | Analysis | Estrogen | Antagonists | Hormones
Journal Article
Pediatrics, ISSN 0031-4005, 04/2009, Volume 123, Issue 4, pp. e752 - e762
OBJECTIVE. Gonadotropin-releasing hormone analogs revolutionized the treatment of central precocious puberty. However, questions remain regarding their optimal...
Development | GnRH analogs | Precocious puberty | development | precocious puberty | BONE-MINERAL DENSITY | BAYLEY-PINNEAU METHOD | CENTRAL PRECOCIOUS PUBERTY | FINAL HEIGHT | ITALIAN STUDY-GROUP | GNRH AGONIST TREATMENT | BODY-MASS INDEX | PEDIATRICS | LONG-TERM TREATMENT | LEUPROLIDE ACETATE DEPOT | SLOWLY PROGRESSIVE PUBERTY | Uterus - pathology | Ovary - pathology | Nafarelin - pharmacology | Humans | Organ Size | Puberty, Precocious - pathology | Puberty, Precocious - psychology | Polycystic Ovary Syndrome - chemically induced | Gonadotropin-Releasing Hormone - analogs & derivatives | Puberty, Precocious - drug therapy | Body Height - drug effects | Bone Density - drug effects | Adolescent | Female | Hypothyroidism - epidemiology | Luteinizing Hormone - pharmacology | Puberty, Precocious - epidemiology | Child | Pediatrics | Puberty | Hormones | Endocrinology | Children & youth | Index Medicus | Abridged Index Medicus | Polycystic Ovary Syndrome | Puberty, Precocious | Bone Density | Hypothyroidism | Luteinizing Hormone | Life Sciences | Ovary | Human health and pathology | Nafarelin | Uterus | Body Height | Gonadotropin-Releasing Hormone
Development | GnRH analogs | Precocious puberty | development | precocious puberty | BONE-MINERAL DENSITY | BAYLEY-PINNEAU METHOD | CENTRAL PRECOCIOUS PUBERTY | FINAL HEIGHT | ITALIAN STUDY-GROUP | GNRH AGONIST TREATMENT | BODY-MASS INDEX | PEDIATRICS | LONG-TERM TREATMENT | LEUPROLIDE ACETATE DEPOT | SLOWLY PROGRESSIVE PUBERTY | Uterus - pathology | Ovary - pathology | Nafarelin - pharmacology | Humans | Organ Size | Puberty, Precocious - pathology | Puberty, Precocious - psychology | Polycystic Ovary Syndrome - chemically induced | Gonadotropin-Releasing Hormone - analogs & derivatives | Puberty, Precocious - drug therapy | Body Height - drug effects | Bone Density - drug effects | Adolescent | Female | Hypothyroidism - epidemiology | Luteinizing Hormone - pharmacology | Puberty, Precocious - epidemiology | Child | Pediatrics | Puberty | Hormones | Endocrinology | Children & youth | Index Medicus | Abridged Index Medicus | Polycystic Ovary Syndrome | Puberty, Precocious | Bone Density | Hypothyroidism | Luteinizing Hormone | Life Sciences | Ovary | Human health and pathology | Nafarelin | Uterus | Body Height | Gonadotropin-Releasing Hormone
Journal Article
2000, Recent results in cancer research, ISBN 3540644296, Volume 153., vi, 97
Book
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2010, Volume 12, Issue 12, p. CD008475
Background Endometriosis is a common gynaecological condition, characterised by the presence of endometrial tissue in sites other than the uterine cavity...
SYMPTOMATIC ENDOMETRIOSIS | SERUM-SOLUBLE CD23 | MEDICINE, GENERAL & INTERNAL | CHRONIC PELVIC PAIN | RANDOMIZED CLINICAL-TRIAL | LOW-DOSE NORETHINDRONE | DOUBLE-BLIND | ADD-BACK THERAPY | QUALITY-OF-LIFE | LEUPROLIDE ACETATE DEPOT | GNRH-AGONIST | Drug Administration Routes | Dyspareunia - drug therapy | Dysmenorrhea - drug therapy | Humans | Endometriosis - drug therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Randomized Controlled Trials as Topic | Pelvic Pain - drug therapy | Estrogen Antagonists - therapeutic use | Pain - drug therapy | Levonorgestrel - therapeutic use | Female | Danazol - therapeutic use
SYMPTOMATIC ENDOMETRIOSIS | SERUM-SOLUBLE CD23 | MEDICINE, GENERAL & INTERNAL | CHRONIC PELVIC PAIN | RANDOMIZED CLINICAL-TRIAL | LOW-DOSE NORETHINDRONE | DOUBLE-BLIND | ADD-BACK THERAPY | QUALITY-OF-LIFE | LEUPROLIDE ACETATE DEPOT | GNRH-AGONIST | Drug Administration Routes | Dyspareunia - drug therapy | Dysmenorrhea - drug therapy | Humans | Endometriosis - drug therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Randomized Controlled Trials as Topic | Pelvic Pain - drug therapy | Estrogen Antagonists - therapeutic use | Pain - drug therapy | Levonorgestrel - therapeutic use | Female | Danazol - therapeutic use
Journal Article
The effects of different gonadotropin releasing hormone analogues in IVF cycles, 12/2005
Objective: To compare Triptorelin, Leuprolide acetate and Nafarelin sodium in women undergoing controlled ovarian hyperstimulation for in vitro fertilization...
Assisted reproductive techniques, GnRH-a, controlled ovarian hyperstimulation, Triptorelin, Nafarelin, Leuprolide acetate
Assisted reproductive techniques, GnRH-a, controlled ovarian hyperstimulation, Triptorelin, Nafarelin, Leuprolide acetate
Journal
Cancer Treatment Reviews, ISSN 0305-7372, 2013, Volume 40, Issue 5, pp. 675 - 683
Abstract Background The role of temporary ovarian suppression with gonadotropin-releasing hormone analogues (GnRHa) in the prevention of chemotherapy-induced...
Hematology, Oncology and Palliative Medicine | Breast cancer | Fertility preservation | GnRH analogues | Lymphoma | Meta-analysis | Chemotherapy-induced ovarian failure | ADJUVANT CHEMOTHERAPY | PROTECTION | GNRH-ANALOGS | PREMENOPAUSAL WOMEN | ONCOLOGY | HODGKIN STUDY-GROUP | EARLY BREAST-CANCER | YOUNG-WOMEN | ORAL-CONTRACEPTIVES | AGONIST | Prognosis | Risk Assessment | Hodgkin Disease - pathology | Humans | Treatment Outcome | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Primary Ovarian Insufficiency - chemically induced | Randomized Controlled Trials as Topic | Young Adult | Clinical Trials, Phase III as Topic | Premenopause - drug effects | Antineoplastic Agents - adverse effects | Breast Neoplasms - pathology | Patient Safety | Hodgkin Disease - drug therapy | Adult | Female | Primary Ovarian Insufficiency - prevention & control | Gonadotropin-Releasing Hormone - therapeutic use | Clinical Trials, Phase II as Topic | Chemotherapy | Pituitary hormones | Gonadotropin | Analysis | Cancer | Index Medicus
Hematology, Oncology and Palliative Medicine | Breast cancer | Fertility preservation | GnRH analogues | Lymphoma | Meta-analysis | Chemotherapy-induced ovarian failure | ADJUVANT CHEMOTHERAPY | PROTECTION | GNRH-ANALOGS | PREMENOPAUSAL WOMEN | ONCOLOGY | HODGKIN STUDY-GROUP | EARLY BREAST-CANCER | YOUNG-WOMEN | ORAL-CONTRACEPTIVES | AGONIST | Prognosis | Risk Assessment | Hodgkin Disease - pathology | Humans | Treatment Outcome | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Primary Ovarian Insufficiency - chemically induced | Randomized Controlled Trials as Topic | Young Adult | Clinical Trials, Phase III as Topic | Premenopause - drug effects | Antineoplastic Agents - adverse effects | Breast Neoplasms - pathology | Patient Safety | Hodgkin Disease - drug therapy | Adult | Female | Primary Ovarian Insufficiency - prevention & control | Gonadotropin-Releasing Hormone - therapeutic use | Clinical Trials, Phase II as Topic | Chemotherapy | Pituitary hormones | Gonadotropin | Analysis | Cancer | Index Medicus
Journal Article
Human Reproduction Update, ISSN 1355-4786, 11/2006, Volume 12, Issue 6, pp. 651 - 671
This systematic review and meta-analysis aimed to answer the following clinical question: among patients treated for IVF with gonadotrophins and GnRH...
Ovarian stimulation | Live birth | GnRH agonist | GnRH antagonist | ANTAGONIST COTREATMENT | LEUPROLIDE ACETATE | PREMATURE LH SURGES | OBSTETRICS & GYNECOLOGY | AGONIST TRIPTORELIN | ASSISTED REPRODUCTION | CONTROLLED OVARIAN HYPERSTIMULATION | REPRODUCTIVE BIOLOGY | live birth | ovarian stimulation | FOLLICLE-STIMULATING-HORMONE | IN-VITRO FERTILIZATION | POOR RESPONDERS | RELEVANT STANDARD | Humans | Probability | Gonadotropins - therapeutic use | Luteinizing Hormone - metabolism | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility Agents - therapeutic use | Pregnancy | Follicle Stimulating Hormone - therapeutic use | Ovulation Induction - methods | Fertilization in Vitro - methods | Female | Live Birth - epidemiology | Gonadotropin-Releasing Hormone - therapeutic use
Ovarian stimulation | Live birth | GnRH agonist | GnRH antagonist | ANTAGONIST COTREATMENT | LEUPROLIDE ACETATE | PREMATURE LH SURGES | OBSTETRICS & GYNECOLOGY | AGONIST TRIPTORELIN | ASSISTED REPRODUCTION | CONTROLLED OVARIAN HYPERSTIMULATION | REPRODUCTIVE BIOLOGY | live birth | ovarian stimulation | FOLLICLE-STIMULATING-HORMONE | IN-VITRO FERTILIZATION | POOR RESPONDERS | RELEVANT STANDARD | Humans | Probability | Gonadotropins - therapeutic use | Luteinizing Hormone - metabolism | Gonadotropin-Releasing Hormone - analogs & derivatives | Fertility Agents - therapeutic use | Pregnancy | Follicle Stimulating Hormone - therapeutic use | Ovulation Induction - methods | Fertilization in Vitro - methods | Female | Live Birth - epidemiology | Gonadotropin-Releasing Hormone - therapeutic use
Journal Article
Human Reproduction Update, ISSN 1355-4786, 2008, Volume 14, Issue 6, pp. 543 - 552
BACKGROUND For preserving fertility in women during chemotherapy, the character of invasive techniques, such as ovarian cryopreservation and other techniques,...
Premature ovarian failure (POF) | Chemotherapy | Oral contraceptives | GnRH-agonist | Gonadotoxicity | ADJUVANT CHEMOTHERAPY | gonadotoxicity | oral contraceptives | GONADOTROPIN-RELEASING-HORMONE | PRIMORDIAL FOLLICLES | PERIPHERAL-BLOOD | PREMATURE OVARIAN FAILURE | chemotherapy | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | HODGKINS-DISEASE | BREAST-CANCER PATIENTS | OOCYTE APOPTOSIS | COMBINATION CHEMOTHERAPY | premature ovarian failure (POF) | YOUNG-WOMEN | Humans | Menstruation Disturbances - prevention & control | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Breast Neoplasms - drug therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Primary Ovarian Insufficiency - chemically induced | Randomized Controlled Trials as Topic | Antineoplastic Agents - adverse effects | Adolescent | Infertility, Female - chemically induced | Adult | Female | Infertility, Female - prevention & control | Primary Ovarian Insufficiency - prevention & control | Gonadotropin-Releasing Hormone - therapeutic use | Contraceptives, Oral - therapeutic use | Menstruation Disturbances - chemically induced | Index Medicus
Premature ovarian failure (POF) | Chemotherapy | Oral contraceptives | GnRH-agonist | Gonadotoxicity | ADJUVANT CHEMOTHERAPY | gonadotoxicity | oral contraceptives | GONADOTROPIN-RELEASING-HORMONE | PRIMORDIAL FOLLICLES | PERIPHERAL-BLOOD | PREMATURE OVARIAN FAILURE | chemotherapy | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | HODGKINS-DISEASE | BREAST-CANCER PATIENTS | OOCYTE APOPTOSIS | COMBINATION CHEMOTHERAPY | premature ovarian failure (POF) | YOUNG-WOMEN | Humans | Menstruation Disturbances - prevention & control | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Breast Neoplasms - drug therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Primary Ovarian Insufficiency - chemically induced | Randomized Controlled Trials as Topic | Antineoplastic Agents - adverse effects | Adolescent | Infertility, Female - chemically induced | Adult | Female | Infertility, Female - prevention & control | Primary Ovarian Insufficiency - prevention & control | Gonadotropin-Releasing Hormone - therapeutic use | Contraceptives, Oral - therapeutic use | Menstruation Disturbances - chemically induced | Index Medicus
Journal Article
Archives of Gynecology and Obstetrics, ISSN 0932-0067, 07/2010, Volume 282, Issue 1, pp. 83 - 88
To determine the protective effect of gonadotropin-releasing hormone analogs (GnRHa) using several ultrasound and endocrine markers to detect ultrastructural...
Chemotherapy | Fertility preservation | Ovarian reserve | Cancer | GnRH analogs | Hodgkin's lymphoma | RHESUS-MONKEYS | GONADOTROPIN-RELEASING-HORMONE | DEPLETION | CHILDHOOD | AGONISTS | FAILURE | OBSTETRICS & GYNECOLOGY | RESERVE | YOUNG-WOMEN | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Gonadotropin-Releasing Hormone - pharmacology | Case-Control Studies | Young Adult | Hodgkin Disease - radiotherapy | Ultrasonography | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Adult | Female | Ovarian Diseases - chemically induced | Ovary - drug effects | Inhibins - blood | Anti-Mullerian Hormone - blood | Gonadotropin-Releasing Hormone - agonists | Ovarian Diseases - blood | Ovary - pathology | Primary Ovarian Insufficiency - blood | Primary Ovarian Insufficiency - chemically induced | Hodgkin Disease - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Primary Ovarian Insufficiency - prevention & control | Ovary - ultrastructure | Follicle-stimulating hormone | Menstruation | Inhibin | Neurohormones | Universities and colleges | Hodgkin's disease
Chemotherapy | Fertility preservation | Ovarian reserve | Cancer | GnRH analogs | Hodgkin's lymphoma | RHESUS-MONKEYS | GONADOTROPIN-RELEASING-HORMONE | DEPLETION | CHILDHOOD | AGONISTS | FAILURE | OBSTETRICS & GYNECOLOGY | RESERVE | YOUNG-WOMEN | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Gonadotropin-Releasing Hormone - pharmacology | Case-Control Studies | Young Adult | Hodgkin Disease - radiotherapy | Ultrasonography | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Adult | Female | Ovarian Diseases - chemically induced | Ovary - drug effects | Inhibins - blood | Anti-Mullerian Hormone - blood | Gonadotropin-Releasing Hormone - agonists | Ovarian Diseases - blood | Ovary - pathology | Primary Ovarian Insufficiency - blood | Primary Ovarian Insufficiency - chemically induced | Hodgkin Disease - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Primary Ovarian Insufficiency - prevention & control | Ovary - ultrastructure | Follicle-stimulating hormone | Menstruation | Inhibin | Neurohormones | Universities and colleges | Hodgkin's disease
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2011, Volume 2011, Issue 11, p. CD008018
Background Chemotherapy has significantly improved prognosis for patients with malignant and some non-malignant conditions. This treatment, however, is...
INDUCED GONADOTOXICITY | GNRH AGONISTS | MEDICINE, GENERAL & INTERNAL | LONG-TERM SURVIVORS | FERTILITY PRESERVATION | HODGKINS-DISEASE | CYCLOPHOSPHAMIDE | EARLY MENOPAUSE | YOUNG-WOMEN | ORAL-CONTRACEPTIVES | LUTEINIZING-HORMONE | Premenopause | Humans | Injections, Intramuscular | Administration, Intranasal | Gonadotropin-Releasing Hormone - analogs & derivatives | Primary Ovarian Insufficiency - chemically induced | Randomized Controlled Trials as Topic | Menstruation - drug effects | Injections, Subcutaneous | Female | Primary Ovarian Insufficiency - prevention & control | Ovulation - drug effects | Gonadotropin-Releasing Hormone - agonists
INDUCED GONADOTOXICITY | GNRH AGONISTS | MEDICINE, GENERAL & INTERNAL | LONG-TERM SURVIVORS | FERTILITY PRESERVATION | HODGKINS-DISEASE | CYCLOPHOSPHAMIDE | EARLY MENOPAUSE | YOUNG-WOMEN | ORAL-CONTRACEPTIVES | LUTEINIZING-HORMONE | Premenopause | Humans | Injections, Intramuscular | Administration, Intranasal | Gonadotropin-Releasing Hormone - analogs & derivatives | Primary Ovarian Insufficiency - chemically induced | Randomized Controlled Trials as Topic | Menstruation - drug effects | Injections, Subcutaneous | Female | Primary Ovarian Insufficiency - prevention & control | Ovulation - drug effects | Gonadotropin-Releasing Hormone - agonists
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 10/2019, Volume 9
Although significant progress has been made in the implementation of new breast cancer treatments over the last three decades, this neoplasm annually continues...
Care and treatment | Breast cancer | Pituitary hormones | Gonadotropin | Drug therapy | Cancer | gonadotropin-releasing hormone (GnRH) | breast cancer | gonadotropin-releasing hormone receptor (GnRHR) | breast cancer adjuvant therapy | GnRH agonist | GnRH analogs
Care and treatment | Breast cancer | Pituitary hormones | Gonadotropin | Drug therapy | Cancer | gonadotropin-releasing hormone (GnRH) | breast cancer | gonadotropin-releasing hormone receptor (GnRHR) | breast cancer adjuvant therapy | GnRH agonist | GnRH analogs
Journal Article
Theriogenology, ISSN 0093-691X, 07/2014, Volume 82, Issue 1, pp. 138 - 143
The aim of this study was to reproductively assess the clinical and hormonal effects of a GnRH agonist (AG) and an antagonist (AN) administered during the...
Neonate | GnRH agonist | Feline | GnRH antagonist | ANTAGONIST | TESTOSTERONE | BEHAVIOR | RATS | CANINE REPRODUCTION | AGONISTS | PUBERTY | REPRODUCTIVE BIOLOGY | SURGE | VETERINARY SCIENCES | SECRETION | GONADOTROPIN | Contraception - veterinary | Cats | Gonadal Steroid Hormones - metabolism | Body Weight | Triptorelin Pamoate - pharmacology | Male | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Sexual Maturation - drug effects | Animals | Time Factors | Triptorelin Pamoate - analogs & derivatives | Behavior, Animal - drug effects | Female | Oligopeptides - pharmacology | Gonadotropin-Releasing Hormone - agonists | Contraception - methods | Testosterone | Puberty | Pituitary hormones | Agricultural societies | Estrogen | Neurohormones
Neonate | GnRH agonist | Feline | GnRH antagonist | ANTAGONIST | TESTOSTERONE | BEHAVIOR | RATS | CANINE REPRODUCTION | AGONISTS | PUBERTY | REPRODUCTIVE BIOLOGY | SURGE | VETERINARY SCIENCES | SECRETION | GONADOTROPIN | Contraception - veterinary | Cats | Gonadal Steroid Hormones - metabolism | Body Weight | Triptorelin Pamoate - pharmacology | Male | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Sexual Maturation - drug effects | Animals | Time Factors | Triptorelin Pamoate - analogs & derivatives | Behavior, Animal - drug effects | Female | Oligopeptides - pharmacology | Gonadotropin-Releasing Hormone - agonists | Contraception - methods | Testosterone | Puberty | Pituitary hormones | Agricultural societies | Estrogen | Neurohormones
Journal Article
13.
Full Text
Gonadotropin‐releasing hormone analogues lead to pro‐inflammatory changes in T lymphocytes
American Journal of Reproductive Immunology, ISSN 1046-7408, 07/2016, Volume 76, Issue 1, pp. 50 - 58
Problem We aimed to investigate the effect of gonadotropin‐releasing hormone (GnRH) analogues on T‐cell immunity. Method of study TNF‐α+‐, INF‐ɣ+‐, IL‐10+‐,...
T helper (TH) 1 immunity | TH17 | GnRH agonist | GnRH antagonist | gonadotropin‐releasing hormone (GnRH) | gonadotropin-releasing hormone (GnRH) | AGONIST BUSERELIN | IMPLANTATION FAILURES | CYTOKINE LEVELS | PERIPHERAL-BLOOD | IMMUNOLOGY | ASSISTED REPRODUCTION | IN-VITRO | REPRODUCTIVE BIOLOGY | MULTIPLE-SCLEROSIS | MESSENGER-RNA | PROSTATE-CANCER | OVARIAN STIMULATION | Th1 Cells - pathology | Inflammation - pathology | Humans | Middle Aged | Gonadotropin-Releasing Hormone - pharmacology | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Inflammation - immunology | Th1 Cells - immunology | Gonadotropin-Releasing Hormone - analogs & derivatives | Immunity, Cellular - drug effects | Inflammation - drug therapy | Buserelin - pharmacology | Adult | Female | Gonadotropin-Releasing Hormone - agonists | Cytokines - immunology
T helper (TH) 1 immunity | TH17 | GnRH agonist | GnRH antagonist | gonadotropin‐releasing hormone (GnRH) | gonadotropin-releasing hormone (GnRH) | AGONIST BUSERELIN | IMPLANTATION FAILURES | CYTOKINE LEVELS | PERIPHERAL-BLOOD | IMMUNOLOGY | ASSISTED REPRODUCTION | IN-VITRO | REPRODUCTIVE BIOLOGY | MULTIPLE-SCLEROSIS | MESSENGER-RNA | PROSTATE-CANCER | OVARIAN STIMULATION | Th1 Cells - pathology | Inflammation - pathology | Humans | Middle Aged | Gonadotropin-Releasing Hormone - pharmacology | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Inflammation - immunology | Th1 Cells - immunology | Gonadotropin-Releasing Hormone - analogs & derivatives | Immunity, Cellular - drug effects | Inflammation - drug therapy | Buserelin - pharmacology | Adult | Female | Gonadotropin-Releasing Hormone - agonists | Cytokines - immunology
Journal Article